News

Bristol Myers Squibb's BMS-986446 receives FDA Fast Track Designation, aiming to transform early Alzheimer disease treatment by targeting tau pathology.

Socrates’ suicide as an affirmative choice.

Late-life depression poses unique challenges, impacting cognitive function and requiring tailored treatment strategies for older adults.

Explore how lifestyle choices like diet, exercise, and sleep enhance mental health outcomes in psychiatry. Share your insights and experiences today with our October theme!

Recent research links nighttime screen use and easy medication access to increased suicide attempts among adolescents, highlighting urgent mental health concerns.

Lipocine Inc. advances LPCN 1154, an oral treatment for postpartum depression, aiming for rapid relief and improved patient access by 2026.

Explore the dramatic evolution of AI, from early concepts to modern chatbots, and the uncertain future they create for humanity.

What disease states are most prominently featured in recent research? Learn more in this exclusive article.

Exploring the intersection of free speech and psychiatry, this article examines societal risks and the ethical responsibilities of mental health professionals.

New phase 3 data highlights seltorexant's potential as a safer adjunctive treatment for major depressive disorder with insomnia, despite not meeting primary end points. Andrew J. Cutler, MD, shares his thoughts.

Psychiatry explores extraordinary experiences like near-death experiences and out-of-body experiences, distinguishing them from mental illness to enhance patient care and understanding.

INmune Bio reveals phase 2 trial results for XPro1595, a novel treatment targeting neuroinflammation in early Alzheimer disease.

In this CME article, explore the complexities of movement disorders in psychiatric practice, including their causes, symptoms, and treatment strategies for better patient care.

Anebulo Pharmaceuticals initiates a phase 1 trial for selonabant, targeting acute cannabis toxicity in children with promising IV treatment potential.

A new study reveals tasimelteon (Hetlioz) significantly improves sleep onset in chronic insomnia patients.

Explore the challenges and strategies of deprescribing in geriatric psychiatry to enhance patient safety and reduce polypharmacy risks.

Explore the evolving understanding of autism, Tylenol use in pregnancy, and the importance of neurodiversity in today's society.

A new study reveals the overwhelming financial and emotional burdens faced by caregivers of individuals with schizophrenia, highlighting urgent support needs.

Geriatric psychiatry faces a growing demand for care. Collaborative models enhance access and improve outcomes for older adults with mental health needs.

Synendos Therapeutics reveals promising phase 1 results for SYT-510, a novel ECS modulator targeting anxiety and CNS disorders with potential for improved patient outcomes.

"Two ways of talking and living in the world.”

A phase 2 study reveals osavampator significantly reduces depression severity in adults with major depressive disorder, showing promise for treatment-resistant cases.

Younger veterans face significantly higher PTSD rates due to social challenges.

New analysis reveals Ingrezza achieves rapid symptomatic remission in tardive dyskinesia, enhancing patient quality of life and reducing disease burden.

Apathy significantly affects cognitive impairment patients, yet remains underrecognized. Discover effective assessment and treatment strategies for improved outcomes.

New phase 2a study reveals promising results for BPL-003, with a 2-dose regimen improving outcomes for patients with treatment-resistant depression.

AI chatbots rapidly integrate into daily life, raising concerns about dependency and mental health risks, paralleling the dangers of drug addiction.

Mass shootings are often misattributed to mental illness, overshadowing the real issues of grievance, radicalization, and access to weapons.

Explore innovative treatments in geriatric psychiatry, focusing on neuroplastic symptoms and emotional awareness therapy for older adults' chronic pain.

Clinicians face challenges in suicide risk assessment, especially with patients denying intent before tragic outcomes. Understanding lethal suicide deniers is crucial.